Akso Health Group Stock EBITDA
| AHG Stock | USD 0.86 0.02 2.27% |
Akso Health Group fundamentals help investors to digest information that contributes to Akso Health's financial success or failures. It also enables traders to predict the movement of Akso Stock. The fundamental analysis module provides a way to measure Akso Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akso Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -8.5 M | -8.1 M |
Akso | EBITDA |
Akso Health Group Company EBITDA Analysis
Akso Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Akso Health EBITDA | (8.5 M) |
Most of Akso Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akso Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Akso EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Akso Health is extremely important. It helps to project a fair market value of Akso Stock properly, considering its historical fundamentals such as EBITDA. Since Akso Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Akso Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Akso Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Akso Ebitda
Ebitda |
|
According to the company disclosure, Akso Health Group reported earnings before interest,tax, depreciation and amortization of (8.5 Million). This is 100.01% lower than that of the Health Care Equipment & Supplies sector and 100.41% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.22% higher than that of the company.
Akso EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akso Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akso Health could also be used in its relative valuation, which is a method of valuing Akso Health by comparing valuation metrics of similar companies.Akso Health is currently under evaluation in ebitda category among its peers.
Akso Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Akso Health from analyzing Akso Health's financial statements. These drivers represent accounts that assess Akso Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Akso Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 176.7M | 20.5M | 33.6M | 8.1M | 26.9M | 25.5M | |
| Enterprise Value | 139.4M | 30.3M | 48.9M | 9.9M | (56.3M) | (53.5M) |
Akso Health Institutional Holders
Institutional Holdings refers to the ownership stake in Akso Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Akso Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Akso Health's value.| Shares | Renaissance Technologies Corp | 2024-09-30 | 152.6 K | Ubs Group Ag | 2024-06-30 | 18.3 K | Geode Capital Management, Llc | 2024-09-30 | 15 K | Rhumbline Advisers | 2024-06-30 | 14.3 K | Millennium Management Llc | 2024-06-30 | 14.2 K | Xtx Topco Ltd | 2024-06-30 | 0.0 |
Akso Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0665 | ||||
| Operating Margin | (4.16) % | ||||
| Current Valuation | 203.22 M | ||||
| Shares Outstanding | 398.82 M | ||||
| Shares Owned By Institutions | 0.07 % | ||||
| Number Of Shares Shorted | 14.11 K | ||||
| Price To Book | 2.54 X | ||||
| Price To Sales | 145.45 X | ||||
| Revenue | 2.41 M | ||||
| Gross Profit | 1.27 M | ||||
| EBITDA | (8.5 M) | ||||
| Net Income | (9.12 M) | ||||
| Cash And Equivalents | 15.46 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.72 X | ||||
| Book Value Per Share | 0.95 X | ||||
| Cash Flow From Operations | 1.35 M | ||||
| Short Ratio | 0.79 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Beta | 0.2 | ||||
| Market Capitalization | 350.96 M | ||||
| Total Asset | 142.02 M | ||||
| Retained Earnings | (63.93 M) | ||||
| Working Capital | 138.42 M | ||||
| Net Asset | 142.02 M |
About Akso Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akso Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akso Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akso Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out Akso Health Piotroski F Score and Akso Health Altman Z Score analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 0.051 | Quarterly Revenue Growth 0.148 | Return On Assets (0.07) | Return On Equity (0.12) |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.